SanBio Company Limited provided earnings guidance for the Fiscal Year Ending January 31, 2023. For the full year, the company expected Operating loss of JPY 8,131 million; Net loss attributable to owners of parent to be JPY 5,684 million and net loss per share of JPY 95.36.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
698 JPY | -17.69% |
|
+3.41% | -0.57% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.57% | 367M | |
+14.76% | 122B | |
+19.34% | 113B | |
+8.24% | 22.84B | |
-19.87% | 20.72B | |
-16.19% | 16.51B | |
-12.87% | 16.39B | |
-44.35% | 15.83B | |
+2.26% | 13.49B | |
+73.29% | 11.67B |
- Stock Market
- Equities
- 4592 Stock
- News SanBio Company Limited
- SanBio Company Limited Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023